The three canonical Ras proteins (KRas, NRas, and HRas) are mutated in a broad range of human cancers with KRAS, NRAS, and HRAS mutations accounting for ∼22, ∼8, and ∼3% of all cancers, respectively (4). This evidence concerns the gene HRAS and cancer.